CRVS vs MSFT: Which Stock is Better?
Side-by-side comparison of Corvus Pharmaceuticals Inc and Microsoft Corporation in 2026
CRVS
Corvus Pharmaceuticals Inc
$14.27
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | CRVS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.04B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | CRVS |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze CRVS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CRVS or MSFT a better investment?
Comparing CRVS and MSFT: Corvus Pharmaceuticals Inc has a market cap of $1.04B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CRVS and MSFT?
CRVS (Corvus Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CRVS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CRVS or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for CRVS.
Which company is more profitable: CRVS or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for CRVS.
Which is the larger company: CRVS or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.04B for CRVS.
Should I buy CRVS or MSFT in 2026?
Both CRVS and MSFT have investment merit. CRVS trades at $14.27 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CRVS and MSFT stock?
Key differences: Market Cap ($1.04B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy CRVS or MSFT in 2026?
The choice between CRVS and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CRVS and MSFT?
CRVS (Corvus Pharmaceuticals Inc) has a market cap of $1.04B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.